The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

Autor: de la Nava D; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Ausejo-Mauleon I; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Laspidea V; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Gonzalez-Huarriz M; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Lacalle A; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Casares N; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Zalacain M; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Marrodan L; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., García-Moure M; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Ochoa MC; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Tallon-Cobos AC; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Hernandez-Osuna R; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Marco-Sanz J; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Dhandapani L; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Hervás-Corpión I; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Becher OJ; Jack Martin Fund Division of Pediatric Hematology-oncology, Mount Sinai, New York, USA., Nazarian J; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland.; Virginia Tech University, Washington, District of Columbia, USA.; Children's National Health System, Center for Genetic Medicine Research, Washington, District of Columbia, USA., Mueller S; University of California, San Francisco San Francisco, California, USA.; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hernaez M; Bioinformatics Platform, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Guruceaga E; Bioinformatics Platform, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Koschmann C; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Venneti S; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Allen JE; Chimerix, Inc. Durham, North Carolina, USA., Dun MD; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Fueyo J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gomez-Manzano C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gallego Perez-Larraya J; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Patiño-García A; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Labiano S; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Alonso MM; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Aug 05; Vol. 26 (8), pp. 1509-1525.

DNA-damaging cancer cells to improve virotherapy.

Autor: Garcia-Moure M; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Tallon-Cobos AC; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Alonso MM; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Oct 21; Vol. 27, pp. 124-125. Date of Electronic Publication: 2022 Oct 21 (Print Publication: 2022).

Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review.

Autor: Riegger, Jana, Schoppa, Astrid, Ruths, Leonie, Haffner-Luntzer, Melanie, Ignatius, Anita

Publikováno v: Cellular & Molecular Biology Letters; 9/30/2023, Vol. 28 Issue 1, p1-41, 41p

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis.

Autor: Schiff, Michael, Koo, Joe, Jin, Erik, Schiller, Eric, Day, Ashley, Stevens, Rebecca, Laskar, Christina

Publikováno v: Advances in Therapy; Feb2016, Vol. 33 Issue 2, p199-213, 15p

Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis.

Autor: Keating, Gillian

Publikováno v: Drugs; 2013, Vol. 73 Issue 10, p1095-1119, 25p